E. Falkowska

发表

IBC’s 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5–8, 2011, San Diego, CA

G. Helguera, Aroop Sircar, J. Nilvebrant, 2011, mAbs.

Broad neutralization coverage of HIV by multiple highly potent antibodies

Pham Phung, Terri Wrin, Chi-Huey Wong, 2011, Nature.

Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.

E. Falkowska, Hui Xiao, T. Dragic, 2011, Vaccine.

Rational immunogen design to target specific germline B cell receptors

David Nemazee, Oleksandr Kalyuzhniy, Skye MacPherson, 2012, Retrovirology.

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data

Andrew L. Ferguson, Michael S. Seaman, Arup K. Chakraborty, 2013, PloS one.

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies

D. Burton, H. Schuitemaker, T. Wrin, 2015, PLoS pathogens.

PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4

Tongqing Zhou, Terri Wrin, Peter D. Kwong, 2012, Journal of Virology.

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

E. Falkowska, J. Reinus, Tatjana Dragic, 2007, Journal of Virology.

L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.

E. Falkowska, Paul J Maddon, W. Olson, 2006, The Journal of general virology.

Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers.

Wayne C Koff, Chung-Yi Wu, Chi-Huey Wong, 2014, Immunity.

Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.

James C Paulson, Pascal Poignard, Ian A Wilson, 2014, Immunity.

Anti-HIV B Cell Lines as Candidate Vaccine Biosensors

J. Mascola, J. Binley, R. Wyatt, 2012, The Journal of Immunology.

Edie Garcia , John Neutralization andGlycans Modulate Entry , CD 81 Binding , Hepatitis C Virus Envelope Glycoprotein E 2

E. Falkowska, J. Reinus, T. Dragic, 2007 .

Rational immunogen design to target specific germline B cell receptors

L. Stamatatos, A. McGuire, D. Nemazee, 2012, Retrovirology.

Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization

E. Falkowska, J. Reinus, T. Dragic, 2007, Journal of Virology.